Table 3.
Waitlist outcomes of liver transplant waitlist registrants with and without hepatitis C (HCV), by cohort.
| HCV | Cohort 1 (2004) n=2,408 | Cohort 2 (2009) n=2,402 | Cohort 3 (2014) n=2,817 |
|
| |||
| Status at 1 year after start date, n (%) | |||
| Alive and waiting | 1,549 (64.3) | 1,511 (62.9) | 1,782 (63.3) |
| Underwent transplantation | 515 (21.4) | 512 (21.3) | 533 (18.9) |
| Died | 275 (11.4) | 277 (11.5) | 330 (11.7) |
| Withdrawn from waiting lista | 69 (2.9) | 102 (4.2) | 172 (6.1) |
| Follow-up, months, median (IQR) | 12.0 (7.9–12.0) | 12.0 (7.1–12.0) | 12.0 (7.3–12.0) |
|
| |||
| Non-HCV | Cohort 1 (2004) n=3,592 | Cohort 2 (2009) n=4,164 | Cohort 3 (2014) n=5,992 |
|
| |||
| Status at 1 year after start date, n (%) | |||
| Alive and waiting | 2,293 (63.8) | 2,626 (63.1) | 3,889 (64.9) |
| Underwent transplantation | 780 (21.7) | 834 (20.0) | 1,020 (17.0) |
| Died | 397 (11.1) | 446 (10.7) | 685 (11.4) |
| Withdrawn from waiting listb | 122 (3.4) | 258 (6.2) | 398 (6.6) |
| Follow-up, months, median (IQR) | 12.0 (8.0–12.0) | 12.0 (7.4–12.0) | 12.0 (7.9–12.0) |
a
Withdrawn for following reasons: condition improved-transplant not needed (0.3%, 1.5%, 2.2% of Cohort 1, Cohort 2 and Cohort 3 respectively); refused transplant, unable to contact candidate, or other.
b
Withdrawnfor following reasons: condition improved-transplant not needed (1.0%, 2.8%, 2.9% of Cohort 1, Cohort 2 and Cohort 3 respectively); refused transplant, unable to contact candidate, or other.
Abbreviation: MELD, Model for End-stage Liver Disease